Hepatitis B virus variants harboring nucleotide alterations in the preC-C promoter have been detected in fulminant hepatitis B as well as in HBeAg-seronegative persistent infection. However, it has not been demonstrated that variants with nucleotide alterations in the preC-C promoter cause various disease states. We replaced the preC-C promoter region of a wild-type genome with the most frequent naturally occurring mutated form and introduced it into HepG2 cells. The mutant with coexisting A1762T and G1764A substitutions produced less than one-fifth of the wild-type level of HBeAg. Conversely, the mutant generated 2.4 times more core particle antigen and showed a high-replicator phenotype. RNase protection and quantitative 5 RACE showed a 16-to 32-fold reduction of preC transcripts and a 4-fold induction of C transcripts of the mutant compared to wild-type. The preC transcript of the mutant had a more heterogeneous 5 end than that of the wildtype. However, the mutations did not alter the initiation sites of C transcription. When the promoter region was cloned into CAT plasmids, the mutations had dual effects on preC and C promoter activities, decreasing and increasing them, respectively. These results suggest that these mutations are responsible for the reduced HBeAg production as well as the enhanced replication and core production. Analysis of revertants with either single point mutation showed that T at 1762 is critical for the mutant phenotype. ᭧
INTRODUCTION
sis of nucleotide sequence data for the HBV genome suggests that nonsense mutations within the preC open The hepatitis B virus (HBV) e antigen (HBeAg) precurreading frame (ORF) (Brunetto et al., 1989; Carman et al. , sor is translated from over-genome length 3.5-kb tran-1989; Kosaka et al., 1991 ; Omata scripts, which initiate 22 to 28 bp upstream from Liang et al., 1991) as well as nucleotide precore (preC) initiation codon (Yaginuma and Koike, substitutions, insertions, and deletions in the preC-C pro-1989; Chen et al., 1993) . The 214 amino acid (aa) long moter region (Feitelson et al., 1991; Kim et al., 1992; Repp precursor (212 aa in several subtypes carrying a 6-bp et al., 1992; Preisler-Adams et al., 1993; Laskus et al., shorter C gene) loses the amino-terminal 19 aa, con-1994; Moriyama et al., 1994; Horikita et al., 1994 ; Okataining the signal sequence, after the protein translomoto et al., 1994; Sato et al., 1995) might be factors decates cotranslationally into the endoplasmic reticulum.
termining the HBeAg-negative phenotype and the severThis processed protein then loses 36 (or 34) aa from ity of hepatitis. In the preC-C promoter mutants, altered the carboxyl-terminal in the Golgi apparatus (Bruss and residues are usually between positions 1753 and 1772, Gerlich, 1988; Jean-Jean et al., 1989) . The secreted 159-the most common alterations being two coexisting point aa HBeAg circulates in association with plasma proteins mutations, A to T at 1762 (A1762T) and G to A at 1764 (Machida et al., 1991) . Although the secretion pathway (G1764A) . These mutations would that produces circulating HBeAg has been elucidated in directly affect the functions of the overlapping X gene detail, little is known about HBeAg's biological functions.
product. Also, they may affect the enhancer II element, HBV carriers with serum HBeAg generally show high since several proteins bind to the region encompassing levels of virus and higher rates of transmission (Alter et these mutations. al., 1976; Okada et al., 1976; Werner et al., 1977) . On the Since preC nonsense mutations abort the synthesis of other hand, fulminant hepatitis B can occur as a primary HBeAg, seroconversion from HBeAg positive to anti-HBe infection of the virus which has been harbored in an positive is believed to be induced by the immune presHBeAg-negative HBV carrier (Fagan et al., 1986) . Analysure of the host against wild-type (wt) HBV toward predominance of HBeAg-negative mutants. Thus, viruses possessing only mutations within the promoter region ORF mutants. Moreover, such promoter mutants with an (PCR)-based site-directed mutagenesis (Landt et al., 1990) of pYWAG, which was derived from a plasmid pPYW310 intact preC ORF have been found in HBV carriers negative for both HBeAg and anti-HBe  (a pUC119 having at the PstI site a 3182-bp complete HBV genome, subtype ayw and genotype D, which had been Okamoto et al., 1994) . Although these cases are consistent with preC-C promoter mutations being responsible cloned from the serum of an HBeAg-positive carrier ). The two first-step PCRs were performed for the defective production of HBeAg, this has yet to be experimentally proven.
with forward primer B026, 5GACAACTCTGTTGTCCTC-TCC, and mutagenized reverse primers, and reverse The sequence patterns of the preC-C promoter mutations found in Japanese patients with fulminant or severe primer B046, 5TGCTCAGGAGACTCTAAGGC, and mutagenized forward primers. Mutagenized oligonucleotides hepatitis B (Sato et al., 1995) resemble those observed in HBeAg-negative persistence .
were B047, 5AGGTTAATGATCTTTGTACTAG, and B048, 5CTAGTACAAAGATCATTAACCT, for pYWTA (1762 A to However, it has not been determined if these promoter mutations played a causal role in the severity of the T, 1764 G to A), B071, 5GATTAGGTTAATGGTCTTTG-TAC, and B072, 5CAAAGACCATTAACCTAATCTCCT, for disease. Some investigators have proposed that the fulminant phenotype is not solely attributable to preC transpYWTG (1762 A to T), B073, 5ATTAGGTTAAAGATCTTTG-TACTA, and B074, 5ACAAAGATCTTTAACCTAATCTCCT, lational termination (Ogata et al., 1993; Hasegawa et al., 1994) , based on intensive in vitro analysis, and experifor pYWAA (1764 G to A) and B064, 5TGGGTGGCTTTA-GGGCATGGAC, and B065, 5ATGTCCATGCCCTAAAGCC-mental infection of chimpanzees, using clinical sample HBV harboring both the preC-C promoter and preC ORF ACCCA, for pYWPCTer. Second PCR products using primers B026 and B046 encompassed positions 1333 to 2040 mutations along with several sequence variations in other regions.
of HBV. Both ends of the 1.1-kb fragments were digested with NcoI and SacII and replaced with the wt NcoI-SacII The C gene product, HBcAg, is translated from another 3.5-kb transcript, of which the 5 end is 29 to 35 nucleofragment of pPYW310. The replication-competent homogeneous tandem dimer of the 6.4-kb HBV genome was tides shorter than that of the preC mRNA, and in which the preC initiation codon is absent. This transcript also cloned at the unique PstI site of pUC119 and designated p2WAG (from pYWAG), p2WTA (pYWTA), p2WTG (pYWTG), serves as the mRNA for the DNA polymerase-reverse transcriptase (pol) and as the pregenome (Seeger et al., or p2WAA (pYWAA) (Fig. 1) . The relative orientation of the viral DNA and vector DNA was identical for the dimer 1986; Will et al., 1987; Enders et al., 1987; Nassal et al., 1990) , which is the template for the reverse transcription constructs. p2WAG and p2WTA were cleaved at the unique SphI site at position 1233, and the monomeric replicationof pol (Ou et al., 1990) . C gene transcription is controlled by the upstream regulatory element and the basic C proincompetent 3.2-kb HBV DNA was cloned at the SphI site of pUC19 and designated pSpAG (from p2WAG) or pSpTA moter (position from 1643 to 1849) and negative regulatory element (1611 to 1634) (Honigwachs et al., 1989; Lo (from p2WTA) . Plasmid DC has a tandem dimer with 2-bp deletion at positions 2003 and 2004 in the C ORF (Okamoto and Ting, 1994) . However, the role of this promoter region in transcription of the overlapping preC has not been et al., 1990) . This frame shift mutation alters C peptide aa sequence from 35 and prematurely terminates its translaclosely examined.
Another interesting finding among the promoter mution at 45. To construct pBasic.d5CAT, in which 38-bp was detants is that a one-point mutation has not been found in any variants, even some quasi-species consist of such a leted from the 5 untranslated region (UTR) of the chloramphenicol acetyl transferase (CAT) gene of pCAT-Basic two-point mutation clone and a wt clone. Why are multiply substituted mutants selected or replicatively superior to (Promega), part of the CAT ORF encompassing the region from the initiation codon to a unique NcoI site was amplithe presumptive single-substituted mutants. Is a singlesubstituted residue responsible for the HBeAg-seronegafied by PCR using primers B077, 5GACTCTAGACTA-AAATGGAGAAAAAAATCA, and B078, 5CAGCACCTT-tivity and another for the severity of the disease.
In this study, we demonstrated that the A1762T, GTCGCCTTGCG, and ligated with the larger fragment of XbaI and NcoI-digested pCAT-Basic DNA. For pAG.d5-G1764A double mutation is responsible for defective production of HBeAg at the transcriptional level and for en-CAT, pTA.d5CAT, pTG.d5CAT, and pAA.d5CAT, a DNA fragment from position 1630 to 1799 of each wt or mutahanced HBcAg production and replication. Moreover, we attempted to resolve the reason of the coexistence of genized HBV DNA was amplified by PCR using primers B067, 5GGAGTCGACCAAATCTTGCCCAAGGTCT, and the two nucleotide changes in one clone by analyzing the single-substituted revertants.
B068, 5TGCGTCGACCAATTTATGCCTACAGCC, both of which contain a created SalI site, and cloned into the
MATERIALS AND METHODS
SalI site of the pBasic.d5CAT (Fig. 5A ). For pAG.79.CAT, Plasmids pTA.79.CAT, pTG.79.CAT, and pAA.79.CAT, each HBV DNA between positions 1630 and 1846 was amplified Plasmids carrying an HBV DNA with preC-C promoter mutations were produced by polymerase chain reaction with primers B067 and B079, 5CAGATCTAGAGATGAT-TAGGCAGAGGTG, digested with SalI and XbaI, and then TBST, the membrane was incubated with horseradish peroxidase-labeled anti-mouse immunoglobulin antibodcloned into the SalI-XbaI-digest of the pCAT-Basic vector.
ies and then examined using a chemical luminescence system (Amersham). Transfection and ELISA of HBV antigens and hGH Southern blotting HepG2 cells (Aden et al., 1979) were cultured in 60-mm dishes containing DMEM supplemented with 10%
To isolate encapsidated viral DNA, 4 ml of culture medium was centrifuged at 273,000 g for 3 hr. The pellet calf serum (CS). Recombinant plasmids were introduced into the cells using polycationic lipids (LipofectAMINE, was suspended in 1 ml PBS, overlaid on 3.5 ml of 20% sucrose-PBS, and centrifuged 273,000 g for 3 hr. The Gibco). For triplicate transfection, 15.0 mg of plasmid carrying HBV genomes and 3.0 mg of pTKGH (Selden et al., resulting pellet was suspended in 1 ml of 10 mM TrisHCl, pH 8.8, 5 mM CaCl 2 , and 1 U/ml staphylococcal 1986) were mixed with 90 ml of the lipid solution in 1200 ml of reduced serum medium (Gibco), and the mixture nuclease (Sigma). The reaction mixture was diluted to 0.5% (wt/vol) in SDS and 0.2 mg/ml in proteinase K and was incubated at 22Њ for 30 min then diluted with 4.8 ml of the reduced serum medium. Two milliliters of this diluted further incubated at 55Њ for 2 hr. DNA was extracted with phenol and chloroform and precipitated with ethanol. The mixture per dish was overlaid on the cells. After 6 hr of incubation at 37Њ, 2.0 ml of DMEM containing 20% CS DNA was then completely digested with DpnI, subjected to electrophoresis in 1.0% agarose gel, and blotted onto was added, and the dishes were further incubated for 12 hr. Then the culture medium was replaced with 4 ml a nylon filter membrane. Hybridization was carried out with PCR-amplified HBV DNA (spanning positions 747-of fresh DMEM containing 10% CS.
For ELISA of the cell lysates for HBV antigens, cells 1823 and 2413 -3182/1 -197 of pPYW310) labeled with [a 32 P]dCTP, and the filters were washed under highly were rinsed 3 times with 5 ml of phosphate-buffered saline (PBS), scraped into 1 ml of PBS, and collected in the stringent conditions. Radioactivity of specific bands was counted with a BAS 2000 image analyzer (Fuji Film, bottom of a sample tube by brief centrifugation. The cell pellet was suspended in 200 ml of 0.25 M Tris-HCl, pH Tokyo). 7.5, and stored at 070Њ. For ELISA, an equal volume of Ribonuclease protection assay and 5 anchored RACE 21 lysis solution consisting of 150 mM NaCl, 20 mM EDTA, pH 8.0, and 1 mM PMSF (Sigma) was added to the Cells in a 60-mm dish were harvested 48 hr after transsuspension, and then the mixture was vortexed for 15 sec fection with either p2WAG or p2WTA. Total RNA was and centrifuged at 12,000 g for 3 min. Part of the supernaisolated as described previously (Edwards et al., 1991) , tant was then diluted to an adequate concentration to fit treated extensively with DNase1, and poly(A) RNA was within the linear range of light absorbance. HBsAg was isolated using an oligo-dT cellulose column. For the ribotested using anti-HBs horse serum as an immobilized probe, the HBV sequence between the Sau3AI site at antibody and sandwiched with a monoclonal antibody 1762 and the StyI site at 1883 of pYWTA was excised (mAb) against the common determinants of HBsAg (No. and cloned into the BamHI site of pBluescriptKS/ (Stra-824) (Usuda et al., 1986) . Hepatitis B nucleocapsid antigen tagene). The resulting clone, pKSuSy, bearing one copy (HBcAg), representing viral C particles, was determined of the insert oriented so that the BglII end ligates to the by sandwiching it between two mAbs of distinct specificity T3 promoter side, was used. The unique XbaI site of (Nos. 3120 and 3105) (Takahashi et al., 1983) . Similarly, pKSuSy, which exists between the T7 promoter and the HBeAg was determined by sandwiching it between two Sau3AI end of the cloned fragment, was cleaved, and mAbs (Nos. 904 and 905) (Imai et al., 1982) . The amount an RNA probe was synthesized in vitro using T3 RNA of human growth hormone (hGH) in the culture supernapolymerase in the presence of [ 32 P]rCTP. Two microtant was determined with an hGH ELISA kit (Boehringergrams of total RNA or 0.5 mg mRNA of each transfected Mannheim) and substrate OPD (Sigma).
monolayer culture was hybridized with riboprobe in molar excess (Herbomel et al., 1984) . After digestion with SDS-PAGE and immunodetection RNase A and T1 (Boehringer Mannheim), the protected RNA was electrophoresed in a 15% acrylamide gel. For detection of HBeAg and C peptides, 5 ml of culture medium or cell lysate was mixed with an equal volume
The quantities and 5 ends of both the preC and C mRNA were also determined by 5 anchored rapid ampliof 21 gel-loading buffer and a total of 10 ml was subjected to SDS-PAGE, followed by transfer to a nitrocellufication of cDNA ends (RACE) of polyadenylated RNA. cDNA was synthesized with primer B046 using reverse lose filter membrane. The membrane was immersed in Tris-buffered saline (TBST) (10 mM Tris-HCl, pH 7.5, 0.15 transcriptase (Superscript II, Gibco) and appended buffer. After removal of RNA by adding a 1/10 vol of 2 N M NaCl, 0.1% (vol/vol) Tween-20) containing 5% skim milk and incubated at 22Њ for 60 min with primary mAb (No.
NaOH and incubation at 50Њ for 30 min, excess primers and dNTP were removed by passage through an agarose 2221) (Machida et al., 1991) . After being washed with (Yuh et al., 1992) , liver-specific enhancer II (EnhII) (Wang et al., 1990 , Yee, 1989 , negative regulatory element (NRE) (Lo and Ting, 1994), DR1, DR2, and the pregenome encapsidation signal (e) (Junker-Niepmann et al., 1990) are presented. (B) The sequence of wt HBV DNA contained in p2WAG is indicated at the top. AT-rich regions are indicated by underlines. The previously reported transcription initiation sites for preC and C mRNAs, start codons for preC and C, are indicated. Three created mutations are listed below. Dashes represent nucleotides identical to those of p2WAG. All plasmids harbor a homogeneous tandem dimeric HBV genome connected with pUC119 at the unique PstI site at position 515 of HBV. (C) Dashes represent amino acids identical to those of p2WAG.
column (Chromaspin-100, Funakoshi, Tokyo) and the pTKGH with polycationic lipids. Six days after transfection, the cells were harvested and their extract was prepared cDNA was ligated with 5 phosphorylated and 3 aminated 46-mer anchor deoxyoligonucleotide B100, 5 PO 4 -as described above. CAT polypeptide was quantified with a CAT-ELISA kit (Boehringer-Mannheim) and OPD. For 5 GCACTTGACTAGGATCCACTGAATTCTTTAGTGAGG-GTTAATTGCC-NH 3 , using T4 RNA ligase (Takara, Shiga, RACE of CAT mRNA, cDNA was synthesized using a primer B078, CAGCACCTTGTCGCCTTGCG, as described Japan). After a 24-hr ligation reaction in 10 ml of reaction mixture at 16Њ, half of the mixture was used for the first above. The PCR was performed using primers BUPC, 5AAGGCCGTAATATCCAGC, and B101. PCR with primers B101, 5GGCAATTAACCCCTCACT-AAAG, and B102, 5GCCACCCCAAGGCACAGCTTG, which anneal with the anchor and cDNA, respectively. RESULTS The nested PCR was performed using primers B103, Antigen production and replication of the preC-C 5AAAGAATTCAGTGGATCCTAG, and B104, 5ACA-promoter mutant GAATTCAGCTTGGAGGCTTGAACAGT. The EcoRI-and BamHI-digested PCR product was cloned into pUC19, and
We set out to clarify how the previously reported nuclethe 3 end of the cDNA was determined by sequencing.
otide substitutions in the preC-C promoter are associated CAT-ELISA and 5 RACE with the HBeAg-seronegative phenotype and fulminant hepatitis B. We first constructed a homogeneous tandem For CAT-ELISA, HepG2 cells in a 60-mm dish were transfected with 5 mg of CAT plasmid along with 1 mg of dimer of the entire HBV genome containing the preC-C b Light absorbance for each antigen was converted to an absolute unit using the standard curve, divided by the absolute unit for each hGH, and the average and 1 SD of the resulting triplicate relative units are shown in parentheses. Plasmid DC has a tandem dimer with a 2-bp deletion at positions 2003 and 2004 in the C ORF and was used as a negative control plasmid for HBcAg and HBeAg.
promoter substitutions. p2WTA harbors the most comboth cases began to decrease at 48 hr. The rise and fall of HBeAg showed similar time courses for both p2WTA mon preC-C promoter mutation, A1762T and G1764A (deduced HBx aa substitutions Lys130Met and Val131Ile).
and p2WAG (Fig. 3 ). HBeAg production was followed by long-term culture with changes of medium every 3 days; We then compared the properties of HepG2 cells transfected with p2WTA vs wt, p2WAG (Fig. 1) . p2WTA rethe HBeAg production was restored by replacing the culture medium. However, maximum HBeAg titers at 48 hr leased HBeAg into the culture medium at a level detectable by ELISA. However, the quantity of released antigen were reduced by every change of medium, and by the third change the minimum ratio of HBeAg titer for p2WTA 72 hr after transfection was reduced to 40% of the level of p2WAG-transfected cells (Table 1) . HBsAg titer was reached only one-fifth that of p2WAG (Fig. 3 ). 60% that of p2WAG-transfected cells. Moreover, the mutant induced 2.4 times the amount of HBcAg in the HepG2
Quantitation and mapping of preC and C transcripts cells in comparison to p2WAG-transfected cells. Similar changes in the antigen titers were observed with the RNase protection assays (RPAs) with mRNA from transfected cells showed that there was more C tranreplication-defective HBV-DNA monomers (Table 1) .
Western blots of the culture medium showed that the script in cells transfected with p2WTA than that in cells transfected with p2WAG (Fig. 4B) . intensity of the p17 e bands tightly correlated with the HBeAg ELISA titer (Fig. 2A) . Neither C particle-specific The protected product from common ends obscured the preC mRNA band. Thus, we performed semiquantitaantigenicity nor a p21 c band was detected in any culture medium by ELISA (data not shown) or Western blotting, tive anchored 5 RACE. Agarose gel electrophoresis of RACE products showed markedly (16-to 32-fold) reduced respectively. Thus, only the secretory form of HBeAg (p17 e ), and not the HBeAg precursors or degraded forms preC transcripts as well as 4-to 8-fold inductions of C transcripts of p2WTA (Fig. 4C) . Similar results were of C peptide polymer which harbor cryptic HBe-antigenicity, were quantified by ELISA of the culture medium.
obtained with oligo-dT-purified mRNA (not shown). Sequencing of the RACE products showed altered tranWestern blots of the cell extracts showed a 21-kDa band ( Fig. 2A) , confirming the high HBcAg titer.
scriptional initiation points for the p2WTA preC mRNA, scattered between 1759 and 1797. However, the initiation We have demonstrated in vitro the HBeAg-reduced phenotype of the promoter mutant, as had been predicted site of the C mRNA was the same for p2WTA and p2WAG (Fig. 4D ). based on clinical observations. Moreover, we found herein the enhanced C particle production of the mutant.
We quantified both preC and C promoter activities using the CAT gene as a reporter, so that the altered overSouthern blots of progeny virus DNA in the culture medium showed that cells transfected with p2WTA relapping X gene products and preC-mediated inhibition (Lamberts et al., 1993) would not be involved. pAG.d5-leased three times more encapsidated virus DNA than those transfected with the p2WAG (Fig. 2B) .
CAT and its derivative harbor either a wt or a mutated 170-bp fragment from positions 1630 to 1799. The inWe plotted the HBeAg and HBsAg titers of the culture medium every 12 hr after transfection. The cells transserted region contains the third AT-rich region that can serve as the initiator for the preC transcripts when cloned fected with either p2WAG or p2WTA produced HBsAg at a constant rate up to 72 hr, whereas the HBeAg titers in downstream from a heterogeneous enhancer (Chen et Table 1 . p2WPCTer carries a dimeric HBV DNA harboring a nonsense mutation in the preC region (G1896A). e, affinity-purified HBeAg from pooled carrier serum. c, affinity-purified HBcAg produced by an integrated HBV DNA in hepatoma tissue transplanted subcutaneously into nude mice (Matsui et al., 1986) . ( al., 1995). The fragment was inserted 14-bp upstream of determined why such mutants are selected or if they the CAT initiation codon, and only transcripts that are have a replicative advantage over the hypothetical sininitiated upstream from the CAT initiation codon (preC gle-point mutants. Nor has it been determined if one of initiation codon equivalent) can be translated. Thus the the substituted residues is responsible for decreased p.d5CAT series tests preC promoter activities (Fig. 5A) .
HBeAg production and another for increased HBcAg proWhen transfected into HepG2 cells, pTA.d5CAT, harborduction. We constructed revertant plasmids harboring ing the TA mutation, produced 20% of the CAT antigen the mutated HBV genome with either A1762T (p2WTG) or produced by pAG.d5CAT (Fig. 5B) .
G1764A (p2WAA), and compared their phenotypes with The p.79.CAT series carries a mutated 216-bp fragthose of the wt (p2WAG) and the double mutant (p2WTA). ment from position 1630 to 1846 (Fig. 5A) . The inserted Compared to wt p2WAG, p2WTG-transfected HepG2 promoter fragments contain the preC initiation codon, cells produced lower HBsAg and HBeAg and abundant but this reading frame terminates at the TAA codon 13
HBcAg. Whereas, p2WAA produced lower amounts of bp upstream from the CAT initiation codon. Thus, the HBsAg but the same amount of HBeAg as the wt trans-CAT antigen titer should reflect only the C transcript fected cells (Table 2) . When the replication capacity of equivalents, which start downstream from the 1814 preC these four HBV types were compared by the Southern initiation codon. Consequently, pTA.79.CAT produced blots, all tandem dimers with either mutation were replitwofold more CAT than the wt pAG.79.CAT (Fig. 5C) .
cation-competent, but p2WTA and p2WTG released their A semiquantitative 5 RACE of CAT mRNA of pAG.79.-progeny more than the others (Fig. 6 ). CAT and pTA.79.CAT showed 10-to 50-fold reduced preC
When we compared the preC promoter activities of the transcription and 4-to 16-fold enhanced C transcription A1762T-and G1764A-mutants using p.d5CAT plasmids, from the mutant promoter (Fig. 5D) .
the A1762T-mutant (pTG.d5CAT) showed its preC-proTherefore, the mutation alters the initiation sites and moter activity to be stronger than the wt (pAG.d5CAT), reduces the amount of preC mRNA generated. Also, it just like the double-mutant (pTA.d5CAT) (Fig. 5B) . The increases C mRNA generation without altering the initia-G1764A-mutant (pAA.d5CAT) showed similar activity tion site.
of preC promoters as with wt, as indicated by the antigenic phenotype of tandem dimers of genome-length Phenotypic analysis of singly substituted mutants HBV DNA. Our examination of the p.79.CAT series showed that Most of the reported preC-C promoter mutants carry two or more nucleotide substitutions. It has not been the promoter with the A1762T-mutation (pTG.79.CAT)
FIG. 3. Time courses of HBsAg and
HBeAg titers in the culture medium of cells transfected with p2WAG or p2WTA. First, second, third, and fourth medium replacements were performed 1, 4, 7, and 10 days after transfection, respectively. Each 150 ml of the medium was collected every 12 hr after the second medium change. Optical density within a linear range of the sandwich-ELISA for serially diluted samples was used. The mean titers of triplicate cultures were converted to arbitrary units using a standard curve and an hGH titer, as described in Table 1 . Error bars indicate 1 SD for each triplicate culture. displayed the same activity as that with the doublebetween in vivo infection and in vitro transfection. In infections with the preC-C promoter mutants, HBeAg might mutation (pTA.79.CAT), whereas that with the G1764A-mutation (pAA.79.CAT) showed the same activity as the be produced and then cleared to reach a level undetectable in serological tests, even in individuals without any wt (pAG.79.CAT) (Fig. 5C) .
The 5 RACE of CAT mRNA of pTG.79.CAT and detectable anti-HBe antibodies. In our in vitro time courses, HBeAg levels of both wt and mutant HBV markpAA.79.CAT confirmed the reduced preC transcription and enhanced C transcription of the mutant promoter edly decreased in unchanged culture medium between every medium changes (Fig. 3) . The fresh medium might (Fig. 5D) .
Therefore, A1762T is essential and sufficient for the contain some factors that causes the cells to produce HBeAg or that binds to HBeAg to protect it from degradamutant phenotype demonstrated by the double mutant.
tion. We demonstrated that the A1762T, G1764A double mu-DISCUSSION tation directly alters both the preC and C promoter activities decreasing and increasing, respectively. The double Low level production of HBeAg by HBV DNA with the mutation also altered the initiation sites of the reduced preC-C promoter mutations found in patients with level transcripts. However, the mutations did not shift HBeAg-negative persistent infections was demonstrated the initiation site of C transcript; alterations of this site by transfection of cultured cells. However, complete abdetermine the length of 5 UTR and affect the efficiency sence of HBeAg production could not be demonstrated of translation ). It appears that the with this system; one-fifth that of the wt was found. The leaky HBeAg production might be due to the difference third AT-rich region did not work as an initiator of preC The bands for the common region of preS-S, X, and preC-C RNA have slightly different intensities, whereas those for the core mRNA differ. The same result was obtained using total RNA. (C) pTKGH was cotransfected with each CAT plasmid and RNA was obtained from the culture dish producing the same amount of hGH. The RACE products were electrophoresed in 5% agarose gel and visualized with ethidium bromide. The 140-and 100-bp bands correspond with preC and C transcripts, respectively. (D) Each 5 end of preC and C transcripts is represented by a solid circle. The arrows show the created mutation. Start codons for the preC, DR1, as well as the pregenome encapsidation signal (e) (Junker-Niepmann et al., 1990) are indicated. RACE products were digested with BamHI and EcoRI, electrophoresed in 5% agarose gel, and the bands with sizes between 70 and 140 bp were excised and ligated with plasmid vectors. Seven or eight and four clones for preC and C transcriptions, respectively, were picked up and the nucleotide sequences were determined. transcription of the double mutant in our culture system. lated that abortion of HBeAg translation might lead to severe hepatitis. In this study, we demonstrated an addiAlso, the double mutation reduced the amount of preC mRNA and simultaneously increased the C mRNA.
tional mechanism whereby the mutated overlapping preC and C promoter regions directly alter their own activities. Therefore, the nucleotide changes might have altered the affinity of TATA-binding protein for the second ATThis promoter mutation-dependent down-expression of HBeAg might enable the mutants to replicate more easily rich region (Chen et al., 1995) and reduced the preC promoter activity. This hypothesis is supported by the than the partially suppressed wt (Lamberts et al., 1993) , and the mutation-dependent up-regulation of C expresfinding that A1762T was sufficient for the double-mutant phenotype. The down-regulation of preC promoter activsion might promote this replication. The low level production of HBeAg and HBsAg in our ity might have released the downstream C promoter from occlusion by preC transcription. study might explain HBeAg-negative persistence in which the circulating HBV titers are low, whereas the The HBeAg titer from cells transfected with the G1764A-mutation was the same as with wt (Table 2) . enhanced replication and HBcAg production are compatible with severe hepatitis in primary infection. EpidemioTherefore, it seems unlikely that this mutation would be selected in individuals who are seropositive for anti-HBe. logical studies of carrier patients (Alter et al., 1976; Okada et al., 1976) and experimentally infected chimpanzees The G1764A-mutant might exist as an HBeAg-positive wt. The A1762T mutation was essential and sufficient to (Shikata et al., 1977) have demonstrated that the presence of anti-HBe in individuals is closely associated with elicit the mutant phenotype demonstrated by the double mutant (Table 2, Fig. 6 ). Thus, it is still unclear why the decreased copy numbers of the circulating viral genome and low serum infectivity. To account for the high-replitwo-point mutation, but not one-point A1762T-mutation, was selected in vivo.
cator phenotype of mutant HBV in our culture system, a low circulating virus titer in vivo would appear to be cre- Lamberts et al. (1993) observed that preC expression acts to inhibit HBV replication in HepG2 cells and specuated by a subtle balance between viral replication and immunocompetition, rather than the low-replicating nalak et al., 1995). The major T-cell targets are cells presenting HBcAg peptides rather than HBsAg (Cerny et al., ture of these mutants. Nevertheless, HBV carriers with preC-C promoter mutations who are negative for both 1994; Sylvan et al., 1987; Milich and McLachlan, 1988; Inoue et al., 1989) . Thus, enrichment of the HBcAg supply HBeAg and anti-HBe do occasionally exist Moriyama et al., 1994) . They are asymptomatic may lead to severe hepatitis. The original hosts of fulminant infections, who have transmitted the preC ORF muand their circulating virus DNA titers are low. Thus, these persistent infections cannot be clearly explained solely tants to the affected patients, have been reported to be healthy HBV carriers (Fagan et al., 1986; Kojima et al. , in terms of the phenomenon we observed in vitro.
Common HBVs are noncytopathic viruses (Hoofnagle 1991). Therefore, HBeAg-negative viruses including both preC ORF and/or preC-C promoter mutations should be et al., 1987) and the hepatocyte injury itself is caused by the CTL responses against the infected cells (reviewed closely associated with each counterpart disease status. One hypothesis is that the HBeAg-negative high HBcAgby Cerny et al., 1994) , possibly along with ADCC (Micha- a The average light absorbance (A492 1 1000) in ELISA of triplicate cultures. b Light absorbance for each antigen was converted to the absolute unit using the standard curve, divided by the absolute unit of each hGH, and the average and 1 SD of resulting triplicate relative units were represented in parenthesis.
Alter, H. J., Seeff, L. B., Kaplan, P. M., McAuliffe, V. J., Wright, E. C., Gerin, J. L., Purcell, R. H., Holland, P. V., and Zimmerman, H. J. (1976 producer variant emerges in an anti-HBe-positive carrier, Cerny, A., Ferrari, C., and Chisari, F. V. (1994) . The class I-restricted and once the variant has been transmitted to an adult cytotoxic T lymphocyte response to predetermined epitopes in the as a primary infection, a severe fatal immune response hepatitis B and C viruses. Current Topics Microbiol. Immunol. 189, [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] to the infected hepatocytes occurs.
